Teva Pharmaceutical Industries Ltd (TEVA) – Medical Equipment – market share and growth rate.

HTF Market Intelligence released a new research report of 104 pages on title ‘Teva Pharmaceutical Industries Ltd (TEVA) – Medical Equipment – Deals and Alliances Profile’  with detailed analysis, forecast and strategies.

Summary

Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company offers generic medicines in a range of dosage forms, including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, as well as active pharmaceutical ingredients (APIs), the essential raw materials to the drug manufacturing industry. It carries out OTC business principally through PGT Healthcare, a consumer healthcare joint venture with The Procter & Gamble Company (P&G). The company conducts its worldwide operations through a network of global subsidiaries. Teva is headquartered in Petach Tikva, Israel.

 

Teva Pharmaceutical Industries Ltd (TEVA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

 

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

 

Scope

 

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

– Business Description – A brief description of the company’s operations.

– Key Employees – A list of the key executives of the company.

– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.

– Key Competitors – A list of the key competitors of the company.

– Key Recent Developments – A brief on recent news about the company.

 

Reasons to Buy

 

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements

– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

 

Understand the company’s business segments’ expansion / divestiture strategy

– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

 

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company

– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

 

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

 

Stay up-to-date on the major developments affecting the company

– Recent developments concerning the company presented in the profile help you track important events.

 

Gain key insights into the company for academic or business research

– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

 

Note*: Some sections may be missing if data is unavailable for the company.

 

 

Companies Mentioned in Report

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/374319-teva-pharmaceutical-industries-ltd-5

 

Table of Contents 

Table of Contents  2

List of Tables  4

List of Figures  5

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017  6

Teva Pharmaceutical Industries Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017  7

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017  8

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017  9

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017  10

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deal Details  13

Venture Financing  13

Gamida Cell Raises US$10 Million In Series E Financing  13

Teva Pharma Industries Invests In MultiGene Vascular Systems  14

Partnerships  15

Teva Pharma Enters into Agreement with Syqe Medical  15

Teva Pharma Enters into Agreement with Intel  16

MDxHealth Enters into Distribution Agreement with Teva Pharmaceutical  16

Oncotest-Teva Enters into Distribution Agreement with Guardant Health  17

Teva Pharma Enters into an Agreement with Microchips Biotech  18

MDxHealth Enters Into Agreement With Teva Pharma To Commercialize Two Cancer Tests In Israel  19

Teva Pharma Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test  20

Equity Offering  21

Teva Pharma Announces Underwriters Exercise of Over-Allotment of American Depositary Shares  21

Teva Pharma Announces Underwriters Exercise of Over-Allotment of Preferred Shares  23

American Well Raises USD10 Million in Private Placement of Shares  24

Debt Offering  25

Teva Pharma Raises USD354.6 Million in Public Offering of 0.5% Notes Due 2022  25

Teva Pharma Raises USD354.6 Million in Public Offering of 1% Notes Due 2025  27

Teva Pharma Raises USD304 Million in Public Offering of 0.125% Notes Due 2018  29

Teva Pharma Raises USD820 Million in Additional Public Offering of 1.625% Notes Due 2028  30

Teva Pharma Raises USD1.93 Billion in Additional Public Offering of 0.375% Notes Due 2020  32

Teva Pharma Raises USD1.65 Billion in Additional Public Offering of 1.125% Notes Due 2024  34

Teva Pharma Raises USD1.5 Billion in Public Offering of 1.4% Notes Due 2018  36

Teva Pharma Raises USD2 Billion in Public Offering of 1.7% Notes Due 2019  37

Teva Pharma Raises USD3.5 Billion in Public Offering of 3.15% Notes Due 2026  39

Teva Pharma Raises USD3 Billion in Public Offering of 2.2% Notes Due 2021  41

Teva Pharma Raises USD2 Billion in Public Offering of 4.1% Notes Due 2046  43

Teva Pharma Raises USD3 Billion in Public Offering of 2.8% Notes Due 2023  45

Teva Pharma Plans to Raise USD22 Billion in Public Offering of Bonds  46

Acquisition  47

Teva Pharma to Acquire Gecko Health Innovations  47

Teva Pharma Completes Acquisition Of NuPathe For US$144 Million In Tender Offer  48

Teva Pharma Completes Acquisition of MicroDose Therapeutx  50

Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company  51

Clal Biotech Acquires Stake In TransPharma Medical From Teva  52

Cephalon Completes Acquisition Of 20% Stake In Mesoblast  53

Teva Pharmaceutical Industries Ltd – Key Competitors  55

Key Employees  56

Locations And Subsidiaries  58

Head Office  58

Other Locations & Subsidiaries  58

Recent Developments  67

Strategy And Business Planning  67

Oct 26, 2016: Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson  67

Feb 24, 2016: Teva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global Brand  69

Financial Announcements  70

Feb 13, 2017: Teva Reports Full Year and Fourth Quarter 2016 Financial Results  70

Jan 06, 2017: Teva Provides 2017 Financial Outlook  77

Nov 15, 2016: Teva Reports Third Quarter 2016 Results  79

Aug 04, 2016: Teva Reports Second Quarter 2016 Results  81

May 09, 2016: Teva Reports First Quarter 2016 Results  85

Feb 11, 2016: Teva Reports Full Year 2015 and Fourth Quarter Financial Results  89

Corporate Communications  95

Feb 06, 2017: Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman  95

Dec 05, 2016: Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson  97

Nov 08, 2016: Teva Announces Appointment of New Chief Legal Officer  99

Legal and Regulatory  100

Dec 22, 2016: Teva Reaches Settlement with Government on FCPA  100

Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges  101

Other Significant Developments  102

Jul 15, 2016: PhRMA Welcomes Five New Member Companies  102

Jan 25, 2016: Teva Releases Innovation and Social Responsibility Highlights  103

Appendix  104

Methodology  104

About GlobalData  104

Contact Us  104

Disclaimer  104List of Tables

Teva Pharmaceutical Industries Ltd, Medical Equipment, Key Facts, 2016  1

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017  1

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017  6

Teva Pharmaceutical Industries Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017  7

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017  8

Teva Pharmaceutical Industries Ltd, Deals By Market, 2011 to YTD 2017  9

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017  10

Gamida Cell Raises US$10 Million In Series E Financing  13

Teva Pharma Industries Invests In MultiGene Vascular Systems  14

Teva Pharma Enters into Agreement with Syqe Medical  15

Teva Pharma Enters into Agreement with Intel  16

MDxHealth Enters into Distribution Agreement with Teva Pharmaceutical  16

Oncotest-Teva Enters into Distribution Agreement with Guardant Health  17

Teva Pharma Enters into an Agreement with Microchips Biotech  18

MDxHealth Enters Into Agreement With Teva Pharma To Commercialize Two Cancer Tests In Israel  19

Teva Pharma Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test  20

Teva Pharma Announces Underwriters Exercise of Over-Allotment of American Depositary Shares  21

Teva Pharma Announces Underwriters Exercise of Over-Allotment of Preferred Shares  23

American Well Raises USD10 Million in Private Placement of Shares  24

Teva Pharma Raises USD354.6 Million in Public Offering of 0.5% Notes Due 2022  25

Teva Pharma Raises USD354.6 Million in Public Offering of 1% Notes Due 2025  27

Teva Pharma Raises USD304 Million in Public Offering of 0.125% Notes Due 2018  29

Teva Pharma Raises USD820 Million in Additional Public Offering of 1.625% Notes Due 2028  30

Teva Pharma Raises USD1.93 Billion in Additional Public Offering of 0.375% Notes Due 2020  32

Teva Pharma Raises USD1.65 Billion in Additional Public Offering of 1.125% Notes Due 2024  34

Teva Pharma Raises USD1.5 Billion in Public Offering of 1.4% Notes Due 2018  36

Teva Pharma Raises USD2 Billion in Public Offering of 1.7% Notes Due 2019  37

Teva Pharma Raises USD3.5 Billion in Public Offering of 3.15% Notes Due 2026  39

Teva Pharma Raises USD3 Billion in Public Offering of 2.2% Notes Due 2021  41

Teva Pharma Raises USD2 Billion in Public Offering of 4.1% Notes Due 2046  43

Teva Pharma Raises USD3 Billion in Public Offering of 2.8% Notes Due 2023  45

Teva Pharma Plans to Raise USD22 Billion in Public Offering of Bonds  46

Teva Pharma to Acquire Gecko Health Innovations  47

Teva Pharma Completes Acquisition Of NuPathe For US$144 Million In Tender Offer  48

Teva Pharma Completes Acquisition of MicroDose Therapeutx  50

Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company  51

Clal Biotech Acquires Stake In TransPharma Medical From Teva  52

Cephalon Completes Acquisition Of 20% Stake In Mesoblast  53

Teva Pharmaceutical Industries Ltd, Key Competitors  55

Teva Pharmaceutical Industries Ltd, Key Employees  56

Teva Pharmaceutical Industries Ltd, Subsidiaries  58List of Figures

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017  1

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017  1

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017  1

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017  1

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017  6

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017  7

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017  8

Teva Pharmaceutical Industries Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017  9

 

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=374319

 

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

sales@htfmarketreport.com

Ph: +1 (206) 317 1218

Designed by CyFocus.com
Powered by CyFocus.net